136 related articles for article (PubMed ID: 22968517)
1. Preoperative identification of synchronous ovarian and endometrial cancers: the importance of appropriate workup.
Broeders FM; van der Wurff AA; Pijnenborg JM; Vos MC
Int J Gynecol Cancer; 2012 Oct; 22(8):1325-31. PubMed ID: 22968517
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas.
Rodolakis A; Thomakos N; Akrivos N; Sotiropoulou M; Ioannidis I; Haidopoulos D; Vlachos G; Antsaklis A
Arch Gynecol Obstet; 2012 Mar; 285(3):817-21. PubMed ID: 21842403
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
4. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.
Ramus SJ; Elmasry K; Luo Z; Gammerman A; Lu K; Ayhan A; Singh N; McCluggage WG; Jacobs IJ; Whittaker JC; Gayther SA
Clin Cancer Res; 2008 Sep; 14(18):5840-8. PubMed ID: 18794095
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
Oranratanaphan S; Manchana T; Sirisabya N
Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
[TBL] [Abstract][Full Text] [Related]
6. Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor.
Rabban JT; Gupta D; Zaloudek CJ; Chen LM
Gynecol Oncol; 2006 Dec; 103(3):1164-8. PubMed ID: 17034837
[TBL] [Abstract][Full Text] [Related]
7. Synchronous tumors of the female genital tract: a 20-year experience in a single center.
Saatli B; Yildirim N; Ozay AC; Koyuncuoglu M; Demirkan B; Saygili U
Ginekol Pol; 2014 Jun; 85(6):441-5. PubMed ID: 25029809
[TBL] [Abstract][Full Text] [Related]
8. MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors.
Cymbaluk-Ploska A; Chudecka-Glaz A; Surowiec A; Pius-Sadowska E; Machalinski B; Menkiszak J
Asian Pac J Cancer Prev; 2016; 17(5):2597-603. PubMed ID: 27268637
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Coskun F; Basaran M; Salman MC
Eur J Gynaecol Oncol; 2003; 24(2):171-4. PubMed ID: 12701972
[TBL] [Abstract][Full Text] [Related]
10. Synchronous primary cancers of endometrium and ovary vs endometrial cancer with ovarian metastasis: an observational study.
Moro F; Leombroni M; Pasciuto T; Trivellizzi IN; Mascilini F; Ciccarone F; Zannoni GF; Fanfani F; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jun; 53(6):827-835. PubMed ID: 30620432
[TBL] [Abstract][Full Text] [Related]
11. Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review.
Shamshirsaz AA; Withiam-Leitch M; Odunsi K; Baker T; Frederick PJ; Lele S
Gynecol Oncol; 2007 Mar; 104(3):757-60. PubMed ID: 17215032
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in women with synchronous endometrial and ovarian cancers.
Song T; Seong SJ; Bae DS; Kim JH; Suh DH; Lee KH; Park SY; Lee TS
Int J Gynecol Cancer; 2014 Mar; 24(3):520-7. PubMed ID: 24552892
[TBL] [Abstract][Full Text] [Related]
13. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of rising serum CA-125 levels within the normal range in patients with epithelial ovarian, primary peritoneal, and tubal cancers, who, after initial treatment, had a complete clinical response.
Levy T; Weiser R; Boaz M; Shem EB; Golan A; Menczer J
Int J Gynecol Cancer; 2012 Oct; 22(8):1344-8. PubMed ID: 22954785
[TBL] [Abstract][Full Text] [Related]
15. HSP60 predicts survival in advanced serous ovarian cancer.
Hjerpe E; Egyhazi S; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Int J Gynecol Cancer; 2013 Mar; 23(3):448-55. PubMed ID: 23429486
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
Chung HH; Kwon HW; Kang KW; Park NH; Song YS; Chung JK; Kang SB; Kim JW
Ann Surg Oncol; 2012 Jun; 19(6):1966-72. PubMed ID: 22124757
[TBL] [Abstract][Full Text] [Related]
17. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
18. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival.
Williams MG; Bandera EV; Demissie K; Rodríguez-Rodríguez L
Obstet Gynecol; 2009 Apr; 113(4):783-789. PubMed ID: 19305320
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Characteristics and Prognostic Factors of Synchronous Endometrial and Ovarian Cancers-A Single-Institute Review of 43 Cases.
Jain V; Sekhon R; Pasricha S; Giri S; Modi KB; Shrestha E; Ram D; Rawal S
Int J Gynecol Cancer; 2017 Jun; 27(5):938-946. PubMed ID: 28498249
[TBL] [Abstract][Full Text] [Related]
20. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study.
Caldarella A; Crocetti E; Taddei GL; Paci E
Pathol Res Pract; 2008; 204(9):643-8. PubMed ID: 18472354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
